Bacillus subtilis is a rod shaped, gram positive, spore producing bacterium. They are the normal flora of gastrointestinal tract of humans and it is the best characterized model organism for endospore formation. It has the ability to withstand environmental stress, and synthesize beneficial compounds, therefore, it is recognized as a high-quality probiotic supplement. To ensure the probiotic safety and the efficiency, we report the whole genome sequence (WGS) of Bacillus subtilis UBBS-14 strain. The draft genome sequence of Bacillus subtilis UBBS-14 consists of 4,048,984 bp and 4,017 genes, respectively. Bacillus subtilis UBBS-14 does not carry any antibiotic resistant genes containing plasmid, nor it contains any harmful putative virulence factors coding genes, therefore, it confirms the probiotic safety of the respective strain at genome level.
Introduction
Bacillus subtilis are the most widespread bacteria in soil, water, air and gastrointestinal tract of mammals. They are Gram-positive, rod shaped bacteria, known for their ability to produce a robust spore [1] [2] [3] [4] [5] . The complete genome sequence of Bacillus subtilis has deduced the operating mechanisms of the organism [6] . It is well known for its ability to produce secondary metabolites, bacteriocins, enzymes, antibiotics and vaccines [1, [7] [8] [9] [10] [11] [12] . Here, we make an announcement of draft genome of Bacillus subtilis UBBS-14 strain, which was isolated from fermented food at Unique Biotech Limited, Hyderabad, India.
Materials and Methods
Bacillus subtilis UBBS-14 was isolated from the fermented food, the isolate was subjected for DNA isolation and 16S rDNA identification using universal forward 27F (5' AGAGTTTGATCMTGGCTCAG 3') and reverse 1429R (5'TACGGYTACCTTGT TACGACTT3') primers. Following the species identification, the strain was outsourced for WGS (Whole Genome Sequencing) to Genotypic Technology Pvt. Ltd., Bengaluru, India. The whole-genome sequencing was performed using the Illumina MiSeq platform, with a paired-end library; A total of 2,554,530 paired-end raw reads of 150-bp length on average (genome coverage of 189x) were sequenced, out of which, 2,193,966 high quality paired-end reads, with 80% read length scoring Phred quality score of 30 and above, were assembled into 34 Scaffolds by employing de novo genome assembler SPAdesv3.11.1 [13] and scaffolder SSPACE-STANDARD-v.-3.0. [14] . A draft genome map was drawn by using DNA plotter [15] , the origin and terminus were plotted through GenSkew server, and the statistics of genome assembly was calculated by NGS QC Toolkit [16] . The genome sequence was annotated by RAST server [17] and by the NCBI's Prokaryotic Genomes Annotation Pipeline (PGAP) [18] . The gene prediction was carried out using Prodigal program and the predicted proteins were searched for similarity against Uniprot protein database using Blastp program [19] , following pathway identification by KEGG-KAAS server. The
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genome was screened to determine the putative virulence factors (VFDB database) [20] , plasmid (PlasmidFinder 2.0) [21] , and antibiotic resistant genes (ARDB) [22] . BRIG (Blast Ring Image Generator) plot was constructed to compare the assembled genome of Bacillus subtillis UBBS-14 with the standard reference strains Bacillus subtilis subsp., subtilis 168 and Bacillus subtilis BEST195 [23] .
Results and Discussion
The draft genome consists of 4,048,984 bp, with the largest assembled scaffold of 5,60,413 bp length, GC % content of 43.69 ( Figure: 1) , the origin of replication is located at 19,08,765 bp, whereas, the terminus is located at 40,31,869 bp ( Figure: 2). A total of 4,017 genes were predicted, of which 3,845 are coding sequences (CDS), 7 are rRNAs, and 96 are tRNAs. The strain is predicted to encode for about 393 proteins involved in carbohydrate metabolism and 277 proteins involved in amino acid metabolism, and 44 putative proteins for xenobiotics biodegradation and metabolism.
The genes encoding for putative virulence factors such as hemolysin BL, non hemolytic enterotoxin NHE, enterotoxin T, cytotoxin T and cereulide were not found. The genome has no plasmid, the antibiotic resistant genes against Beta-lactam, Fluoroquinolone, Fosfomycin, Fusidic acid, MLS-Macrolide-LincosamideStreptogramin B, Nitroimidazole, Phenicol, Rifampicin, Sulphonamide, Tetracycline, Trimethoprim, Glycopeptide were not found. The genome has Aminoglycoside 6-adenylyltransferase coding gene, the length and amino acid sequence of this particular enzyme is 100 percent identical with the the product of 'aadk' gene of Bacillus subtilis subsp., subtilis 168 strain, which has reported to confer low-level resistance to streptomycin [24] .
The Bacillus subtilis UBBS-14 strain contains genes involved in the biosynthesis of biotin, riboflavin, vitamin K, cobalamin, vitamin B6, folic acid, which leads it to be an nutrition probiotic. It also codes for the antimicrobial peptides such as Bacillaene, Bacillibactin, Surfactin, Fengycin, Bacilycin, and Subtilosin A. The assembled genome of Bacillus subtilis UBBS-14 strain showed 99% sequence identity and 90% coverage with reference Bacillus subtilis Best 195, and 99% sequence identity and 94% coverage with the reference Bacillus subtilis subsp., subtilis 168 ( Figure 3) . The genome analysis of Bacillus subtilis UBBS-14 shows that it does not contain any virulence and antibiotic resistant genes containing plasmid, which ensure its probiotic safety, further studies on the phenotypic characterization of the strain shall give better insights to understand the findings of its genomic characteristics. 
Accession Numbers
This whole-genome shotgun project of Bacillus subtilis UBBS-14 has been deposited in DDBJ/EMBL/GenBank under the accession number RDEZ00000000. The version described in this paper is the first version, RDEZ01000000.
